1. Home
  2. KLTOW vs CFSB Comparison

KLTOW vs CFSB Comparison

Compare KLTOW & CFSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KLTOW
  • CFSB
  • Stock Information
  • Founded
  • KLTOW N/A
  • CFSB 1889
  • Country
  • KLTOW United States
  • CFSB United States
  • Employees
  • KLTOW 3
  • CFSB N/A
  • Industry
  • KLTOW Biotechnology: Biological Products (No Diagnostic Substances)
  • CFSB Major Banks
  • Sector
  • KLTOW Health Care
  • CFSB Finance
  • Exchange
  • KLTOW Nasdaq
  • CFSB Nasdaq
  • Market Cap
  • KLTOW N/A
  • CFSB 51.6M
  • IPO Year
  • KLTOW 2022
  • CFSB N/A
  • Fundamental
  • Price
  • KLTOW $0.25
  • CFSB $13.76
  • Analyst Decision
  • KLTOW
  • CFSB
  • Analyst Count
  • KLTOW 0
  • CFSB 0
  • Target Price
  • KLTOW N/A
  • CFSB N/A
  • AVG Volume (30 Days)
  • KLTOW N/A
  • CFSB 9.9K
  • Earning Date
  • KLTOW N/A
  • CFSB 07-29-2025
  • Dividend Yield
  • KLTOW N/A
  • CFSB N/A
  • EPS Growth
  • KLTOW N/A
  • CFSB N/A
  • EPS
  • KLTOW N/A
  • CFSB N/A
  • Revenue
  • KLTOW N/A
  • CFSB $7,484,000.00
  • Revenue This Year
  • KLTOW N/A
  • CFSB N/A
  • Revenue Next Year
  • KLTOW N/A
  • CFSB N/A
  • P/E Ratio
  • KLTOW N/A
  • CFSB N/A
  • Revenue Growth
  • KLTOW N/A
  • CFSB N/A
  • 52 Week Low
  • KLTOW N/A
  • CFSB $6.34
  • 52 Week High
  • KLTOW N/A
  • CFSB $14.23
  • Technical
  • Relative Strength Index (RSI)
  • KLTOW N/A
  • CFSB 89.92
  • Support Level
  • KLTOW N/A
  • CFSB $13.68
  • Resistance Level
  • KLTOW N/A
  • CFSB $13.70
  • Average True Range (ATR)
  • KLTOW 0.00
  • CFSB 0.01
  • MACD
  • KLTOW 0.00
  • CFSB -0.18
  • Stochastic Oscillator
  • KLTOW 0.00
  • CFSB 100.00

About KLTOW Klotho Neurosciences Inc. Warrant

Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.

About CFSB CFSB Bancorp Inc.

CFSB Bancorp Inc provides banking services. It offers a variety of financial services to individuals and small businesses through its offices in Quincy, Holbrook, and Weymouth. Its primary deposit products are savings, checking, and term certificate accounts, and its primary lending product is residential mortgage loans.The Company's loan portfolio includes residential real estate, commercial real estate, construction, and consumer loan segments. Residential real estate loans include classes for one- to four-family, multi-family, second mortgages and home equity lines of credit.

Share on Social Networks: